Clinical Trial Update: Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

View source ↗

Summary

This clinical trial update describes a prospective, multicenter cohort study evaluating long-term outcomes of Pegylated Interferon alfa-2b in families with clus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Hepatitis B, Chronic (CHB), Hepatitis B | Status: RECRUITING